US Edition
Medicus gains UAE DOH approval for basal cell carcinoma treatment trial
Summary by Clinical Trials Arena
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Medicus gains UAE DOH approval for basal cell carcinoma treatment trial
Medicus Pharma has announced the commencement of the Phase II SKNJCT-004 trial for non-invasive treatment of BCC of the skin.The post Medicus gains UAE DOH approval for basal cell carcinoma treatment trial appeared first on Clinical Trials Arena.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
